Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
04.05.1988 - 18.05.1988
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study (OECD)

Data source

Referenceopen allclose all

Reference Type:
other company data
Title:
Unnamed
Year:
1988
Report date:
1988
Reference Type:
secondary source
Title:
SIDS Initial Assessment Report - 2-Methylbut-3-yn-ol
Author:
BASF AG
Year:
2002
Bibliographic source:
OECD SIDS
Reference Type:
secondary source
Title:
Unnamed
Year:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-methylbut-3-yn-2-ol
EC Number:
204-070-5
EC Name:
2-methylbut-3-yn-2-ol
Cas Number:
115-19-5
Molecular formula:
C5H8O
IUPAC Name:
2-methylbut-3-yn-2-ol
Details on test material:
- Name of test material (as cited in study report): 2-Methylbutin-3-ol-2
- Product No.: 064 522
- Date of bottling: Nov, 1987
- Physical state: liquid, colorless
- Analytical purity: 99.6%
- Storage condition of test material: room temperature

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dr . K . Thomae GmbH, 7950 Biberach
- Age at study initiation: ca. 8 - 9 weeks
- Weight at study initiation: male 259 +/- 6.4 g (average), female 185 +/- 6.5 g (average)
- Identification: colormark on tail
- Housing: 5 per cage, Type D III, Firma Becker
- Diet (e.g. ad libitum): ad libitum, KLIBA Labordiät Ratte/Maus, 24-343-4 10 mm Pellet, Klingentalmühle AG, CH-4303 Kaiseraugst
- Water (e.g. ad libitum): ad libitum


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure:
whole body
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: steel cage placed in Inhalation chamber made of glass and steel
- Exposure chamber volume: ca. 200l
- Method of holding animals in test chamber: single housing
- Source and rate of air: 3000 l/h, central air conditioning system
- System of generating particulates/aerosols: dosing-pump (DESAGA) and glass-vapourizer attached to air-conditioning system
- Temperature, humidity, pressure in air chamber: 20 - 24 °C, 30 - 70% humidity


TEST ATMOSPHERE
- Brief description of analytical method used: Two beakers connected to a fritted glass beaker filled with the solvent 2-propanol.
- Samples taken from breathing zone: yes, once per hour sample, analyzed by gas chromatography with a GC HP 5840A (Hewlett Packard)
Analytical verification of test atmosphere concentrations:
yes
Remarks:
by gas chromatography and substance weight loss during exposure
Duration of exposure:
4 h
Concentrations:
21.3 mg/l
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: prior to begin of study, after 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, mortality
Statistics:
statistic was calculated acc. binominal model

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 21.3 mg/L air
Exp. duration:
4 h
Mortality:
no deaths occured
Clinical signs:
other: - During exposition: accelerated and intermittent respiration, narcotic-like condition, lateral position, anemic pallor - until day 8: Abdominal or lateral position, narcotic-like condition, accelerated to intermittent respiration, reduced general state,
Body weight:
Body weight gain was delayed in the first week compared to historical control, but equals in the second week.
- average weight prior to begin of study: male 259 g, femal 185 g
- average weight after 7 days: 275 g, 198 g
- average weight after 14 days: 315 g, 208 g
Gross pathology:
no findings

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU